The immunological synapse for B-cell memory: the role of the ICOS and its ligand for the longevity of humoral immunity

被引:35
作者
Grimbacher, Bodo [1 ]
Warnatz, Klaus [1 ]
Peter, Hans-Hartmut [1 ]
机构
[1] Univ Freiburg, Dept Rheumatol & Clin Immunol, Med Ctr, Hugstetterstr 55, D-79106 Freiburg, Germany
关键词
ICOS; humoral immunity; memory B cells; immunoglobulin;
D O I
10.1097/01.all.0000104458.09202.24
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Recent findings The ICOS is one of the many costimulatory molecules of T cells. Recently, the authors discovered that the homozygous loss of the ICOS in humans presents as common variable immunodeficiency, the most prevalent treated primary immunodeficiency in man. Therefore, the ICOS is after CD40 and CD40-ligand deficiency the third costimulatory molecule for which a human disease has been described. Purpose of review The description of ICOS deficiency made it necessary to review the vast amount of knowledge from experimental models in the light of a new clinical immunodeficiency phenotype. To this end, after introducing the ICOS and its ligand and comparing the murine and human 'knockout', the role of the ICOS in parasitic and viral infections, asthma, autoimmunity, transplantation immunology, and tumor surveillance will be discussed. Summary The focus of this review is the interaction between the ICOS and its ligand, which is essential for T cell dependent B cell responses.
引用
收藏
页码:409 / 419
页数:11
相关论文
共 69 条
[1]   Characterization of human inducible costimulator ligand expression and function [J].
Aicher, A ;
Hayden-Ledbetter, M ;
Brady, WA ;
Pezzutto, A ;
Richter, G ;
Magaletti, D ;
Buckwalter, S ;
Ledbetter, JA ;
Clark, EA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4689-4696
[2]  
Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745
[3]   Allelic variation of the inducible costimulator (ICOS) gene: detection of polymorphisms, analysis of the promoter region, and extended haplotype estimation [J].
Andersen, ADH ;
Lange, M ;
Lillevang, ST .
TISSUE ANTIGENS, 2003, 61 (04) :276-285
[4]   Potent activity of soluble B7RP-1-FC in therapy of murine tumors in syngeneic hosts [J].
Ara, G ;
Baher, A ;
Storm, N ;
Horan, T ;
Baikalov, C ;
Brisan, E ;
Camacho, R ;
Moore, A ;
Goldman, H ;
Kohno, T ;
Cattley, RC ;
Van, G ;
Gaida, K ;
Zhang, M ;
Whoriskey, JS ;
Fong, D ;
Yoshinaga, SK .
INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (04) :501-507
[5]   A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in Th cells and regulates their responses [J].
Arimura, Y ;
Kato, H ;
Dianzani, U ;
Okamoto, T ;
Kamekura, S ;
Buonfiglio, D ;
Miyoshi-Akiyama, T ;
Uchiyama, T ;
Yagi, J .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (06) :555-566
[6]   Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: Attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses [J].
Bennett, F ;
Luxenberg, D ;
Ling, V ;
Wang, IM ;
Marquette, K ;
Lowe, D ;
Khan, N ;
Veldman, G ;
Jacobs, KA ;
Valge-Archer, VE ;
Collins, M ;
Carreno, BM .
JOURNAL OF IMMUNOLOGY, 2003, 170 (02) :711-718
[7]  
Bertram EM, 2002, EUR J IMMUNOL, V32, P3376, DOI 10.1002/1521-4141(2002012)32:12<3376::AID-IMMU3376>3.0.CO
[8]  
2-G
[9]   ICOS+Th cells produce distinct cytokines in different mucosal immune responses [J].
Bonhagen, K ;
Liesenfeld, O ;
Stadecker, MJ ;
Hutloff, A ;
Erb, K ;
Coyle, AJ ;
Lipp, M ;
Kroczek, RA ;
Kamradt, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (02) :392-401
[10]   The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses [J].
Carreno, BM ;
Collins, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :29-53